Literature DB >> 19892098

Physiotherapy management of axillary web syndrome following breast cancer treatment: discussing the use of soft tissue techniques.

W J Fourie1, K A Robb.   

Abstract

BACKGROUND AND
PURPOSE: Axillary web syndrome (AWS) is becoming increasingly recognised as a sequela of breast cancer treatment. There are currently no formal guidelines on which to base therapy interventions. This case study discusses the physiotherapy management of a patient with AWS, highlighting a soft tissue mobilisation approach. CASE DESCRIPTION: A 47-year-old hairdresser experienced sudden loss of shoulder movement and development of axillary cords 22 days after mastectomy and axillary dissection. The management included manual therapy, mostly using soft tissue treatment techniques, combined with education and advice. OUTCOMES: Pre-morbid range of movement was achieved within 11 treatments, spread over 3 weeks. The patient returned to full-time employment after the seventh treatment by a physiotherapist, within 2 weeks of starting treatment, progressing to full range of shoulder movement with no cords or pain by 16 weeks post surgery. DISCUSSION: Previous theories on the pathophysiology of AWS may need to be revised. Physiotherapy intervention for these patients may prove beneficial in limiting subsequent shoulder dysfunction. Further research is needed to develop a standardised treatment approach for AWS.

Entities:  

Mesh:

Year:  2009        PMID: 19892098     DOI: 10.1016/j.physio.2009.05.001

Source DB:  PubMed          Journal:  Physiotherapy        ISSN: 0031-9406            Impact factor:   3.358


  15 in total

1.  Axillary web syndrome after transaxillary robotic thyroidectomy.

Authors:  Jeong Hwan Kim; Jin Woo Park; Hyun Sik Gong
Journal:  J Robot Surg       Date:  2013-10-08

Review 2.  Axillary Web Syndrome in Breast Cancer: A Prevalent But Under-Recognized Postoperative Complication.

Authors:  Susan R Harris
Journal:  Breast Care (Basel)       Date:  2018-02-01       Impact factor: 2.860

3.  Atypical presentation of axillary web syndrome (AWS) in a male squash player: a case report.

Authors:  Patrick Welsh; David Gryfe
Journal:  J Can Chiropr Assoc       Date:  2016-12

Review 4.  A systematic review of axillary web syndrome (AWS).

Authors:  W M Yeung; S M McPhail; S S Kuys
Journal:  J Cancer Surviv       Date:  2015-02-15       Impact factor: 4.442

5.  Axillary web syndrome is not a risk factor for lymphoedema after 10 years of follow-up.

Authors:  Bárbara Reis Wariss; Rejane Medeiros Costa; Ana Carolina Padula Ribeiro Pereira; Rosalina Jorge Koifman; Anke Bergmann
Journal:  Support Care Cancer       Date:  2016-10-04       Impact factor: 3.603

6.  Cording following treatment for breast cancer.

Authors:  Jean O'Toole; Cynthia L Miller; Michelle C Specht; Melissa N Skolny; Lauren S Jammallo; Nora Horick; Krista Elliott; Andrzej Niemierko; Alphonse G Taghian
Journal:  Breast Cancer Res Treat       Date:  2013-06-29       Impact factor: 4.872

7.  Frequency and associated factors of axillary web syndrome in women who had undergone breast cancer surgery: a transversal and retrospective study.

Authors:  Kassandra Ferreira Pessoa Fukushima; Luana Aroucha Carmo; Adriana Carvalho Borinelli; Caroline Wanderley Souto Ferreira
Journal:  Springerplus       Date:  2015-03-05

8.  High Incidence of Axillary Web Syndrome among Breast Cancer Survivors after Breast Reconstruction.

Authors:  Hsiu-Chen Huang; Hui-Hua Liu; Li-Yun Yin; Chao-Hui Weng; Chien-Liang Fang; Cheng-San Yang
Journal:  Breast Care (Basel)       Date:  2019-11-12       Impact factor: 2.860

9.  Effects of a physical therapy program combined with manual lymphatic drainage on shoulder function, quality of life, lymphedema incidence, and pain in breast cancer patients with axillary web syndrome following axillary dissection.

Authors:  Youngki Cho; Junghwa Do; Sunyoung Jung; Ohyun Kwon; Jae Yong Jeon
Journal:  Support Care Cancer       Date:  2015-11-05       Impact factor: 3.359

Review 10.  Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

Authors:  Suzanne A Eccles; Eric O Aboagye; Simak Ali; Annie S Anderson; Jo Armes; Fedor Berditchevski; Jeremy P Blaydes; Keith Brennan; Nicola J Brown; Helen E Bryant; Nigel J Bundred; Joy M Burchell; Anna M Campbell; Jason S Carroll; Robert B Clarke; Charlotte E Coles; Gary J R Cook; Angela Cox; Nicola J Curtin; Lodewijk V Dekker; Isabel dos Santos Silva; Stephen W Duffy; Douglas F Easton; Diana M Eccles; Dylan R Edwards; Joanne Edwards; D Evans; Deborah F Fenlon; James M Flanagan; Claire Foster; William M Gallagher; Montserrat Garcia-Closas; Julia M W Gee; Andy J Gescher; Vicky Goh; Ashley M Groves; Amanda J Harvey; Michelle Harvie; Bryan T Hennessy; Stephen Hiscox; Ingunn Holen; Sacha J Howell; Anthony Howell; Gill Hubbard; Nick Hulbert-Williams; Myra S Hunter; Bharat Jasani; Louise J Jones; Timothy J Key; Cliona C Kirwan; Anthony Kong; Ian H Kunkler; Simon P Langdon; Martin O Leach; David J Mann; John F Marshall; Lesley Martin; Stewart G Martin; Jennifer E Macdougall; David W Miles; William R Miller; Joanna R Morris; Sue M Moss; Paul Mullan; Rachel Natrajan; James P B O'Connor; Rosemary O'Connor; Carlo Palmieri; Paul D P Pharoah; Emad A Rakha; Elizabeth Reed; Simon P Robinson; Erik Sahai; John M Saxton; Peter Schmid; Matthew J Smalley; Valerie Speirs; Robert Stein; John Stingl; Charles H Streuli; Andrew N J Tutt; Galina Velikova; Rosemary A Walker; Christine J Watson; Kaye J Williams; Leonie S Young; Alastair M Thompson
Journal:  Breast Cancer Res       Date:  2013-10-01       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.